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Abstract
The intraerythrocytic malaria parasite is under constant oxidative stress originating both from
endogenous and exogenous processes. The parasite is endowed with a complete network of
enzymes and proteins that protect it from those threats, but also uses redox activities to regulate
enzyme activities. In the present analysis, the transcription of the genes coding for the antioxidant
defense elements are viewed in the time-frame of the intraerythrocytic cycle. Time-dependent
transcription data were taken from the transcriptome of the human malaria parasite Plasmodium
falciparum. Whereas for several processes the transcription of the many participating genes is
coordinated, in the present case there are some outstanding deviations where gene products that
utilize glutathione or thioredoxin are transcribed before the genes coding for elements that control
the levels of those substrates are transcribed. Such insights may hint to novel, non-classical
pathways that necessitate further investigations.
Introduction
The  Plasmodium-infected erythrocyte is under constant
oxidative stress. This is caused by exogenous reactive oxi-
dant species (ROS) and reactive nitrogen species (RNS)
produced by the immune system of the host, and by
endogenous production of ROS generated during the
digestion of host cell haemoglobin and concomitant bio-
chemical reactions. Small amounts of ROS can also be
produced by the mitochondrial electron transport and by
various metabolic processes. The biochemistry and
molecular biology of antioxidant defense-related enzymes
and intermediates, shown schematically in Fig. 1, have
been extensively discussed in recent reviews [1-5]. The
entire battery of antioxidant enzymes and their substrates
must be functionally present when the parasite starts the
digestion of host cell haemoglobin and when the immune
system starts to be challenged by parasite antigens. These
events start to happen at the late ring-early trophozoite
stage when the parasite engages in intensive digestion of
the host cell haemoglobin and the surface of the erythro-
cyte is sufficiently altered to be recognized by the reticu-
loendothelial system as 'non-self'. Some ROS may escape
the antioxidant defense of the parasite and reach the host
erythrocyte where they are handled by catalase and glu-
tathione peroxidase. However, even this defense system is
not fully effective since the fingerprints of oxidative stress
are discernable in the membrane of the infected red blood
cells (RBC) such as clustering of band 3 [6] and increased
levels of lipid peroxides [7]. It is not intended to review in
depth the redox metabolism of the plasmodium-infected
red blood cell (IRBC), as several recent reviews are availa-
ble. Rather, the stage-dependent transcription of genes
that code for enzymes and proteins that are involved in
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the antioxidant defense of the IRBC will be analysed in a
functional context.
Materials and Methods
The expression data used in this study was obtained from
the DeRisi transcriptome database http://
malaria.ucsf.edu/ of the Plasmodium falciparum intraeryth-
rocytic developmental cycle as described [8]. This data-
base contains the relative mRNA abundance for every
hour of the intraerythrocytic cycle of parasite develop-
ment based on the 70-mer oligonucleotide microarray
[9]. The expression profiles of each transcript is repre-
sented by an array of ratios between the mRNA level in the
time point sample versus a fixed mRNA level in the con-
trol RNA pool. Loess-smoothed expression profiles used
in this study were calculated as described (see [8]). Each
expression profile was subsequently normalized to its
peak value. It is assumed that for each metabolic pathway
there is a stoichiometric relationship among the expres-
sion levels of the individual enzymes and, therefore, the
normalized values are more meaningful for functional
evaluation. Loess-smoothed data were used[8]. All
enzymes and proteins discussed in this essay with their
gene ID's are shown in Table 1.
Results and Discussion
This analysis relates exclusively to the intraerythrocytic
phase of the parasite's life cycle. It should be underscored
that some of the functions assigned to the respective gene
products are putative and have not been verified by bio-
chemical analyses. Such are the cases of thioredoxin-like
proteins (MAL13P1.225, PFI0790w, PFI1250w),
A general scheme showing the various biochemical processes of antioxidant defense Figure 1
A general scheme showing the various biochemical processes of antioxidant defense. TrxS2 and TrxSH2 are oxidized and 
reduced thioredoxin, respectively. GrxS2 and GrxSH2 are oxidized and reduced glutaredoxin, respectively.Malaria Journal 2004, 3:23 http://www.malariajournal.com/content/3/1/23
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glutaredoxin-like proteins (MAL6P1.72, PFC0205c), per-
oxiredoxin (MAL7P1.159), protein disulfide isomerases.
The data that was analysed here are expression levels of
mRNA. This is a long way from what one ideally would
like: expression levels of the functional proteins. The func-
tional meaning of transcription analysis is useful but it
does not tell the complete story of gene expression. Func-
tions are performed by proteins and as long as their stabil-
ity and life span are not known, it may be possible to
imply the onset of expression but not its termination.
Hence, a short-lived transcription may be less informative
than a longer-lived one because the latter indicates that
the protein is expressed at least for this duration of time.
Nevertheless, when transcription is evaluated by consider-
ing a set of biochemically inter-related enzymes and pro-
teins, some information about their coordinated
expression may be gained. In what follows, the different
elements of the redox metabolism of the parasite will be
discussed in functional "clusters", in order to obtain a
methodological overview.
We start our analysis with superoxide dismutase, a major
producer of H2O2 in cells. Then the enzymes involved in
the biosynthesis and recycling of glutathione will be dis-
cussed, followed by those that utilize glutathione. The
thioredoxin system is also discussed in a similar order.
Superoxide dismutase
Intraerythrocytic malaria parasites ingest and digest the
cytosol of their host cell which consists mostly of
haemoglobin. Superoxide (O2
-) is normally produced
when oxidized haemoglobin is exposed to the acid envi-
ronment of the food vacuole, and can therefore be consid-
ered as the major generator of ROS. It is generally
supposed that O2
- is dismutated spontaneously to H2O2
due to the high local H+ concentration, and that the highly
Table 1: Enzymes and proteins involved in redox metabolism and their gene/locus in the P. falciparum genome.
Process Enzyme/protein EC number Gene/locus
ROS generation Fe-superoxide dismutase (possibly an Mn enzyme) 1.15.1.1 PF08_0071
MAL6P1.194
Glutathione biosynthesis and reccycling Glutamate-cysteine ligase 6.3.2.2 PFI0925w
Glutathione synthase 6.3.2.3 PFE0605c
Gluathione reductase 1.8.1.7 PF14_0192
Glutathione-S-transferase 2.5.1.18 PF14_0187
MRP PFA0590w
PFL1410c
Glutathione utilization Glutathione-S-transferase 2.5.1.18 PF14_0187
1-Cys peroxiredoxin PF08_0131
Glutaredoxin PFC0271c
Glutaerdoxin-like protein MAL6P1.72
Glutaerdoxin-like protein PFC0205c
Lactoylglutathione lyase (glyoxalase I) 4.4.1.5 PF11_0145
Hydoxyacylglutathione hydrolase (glyoxalase II) 3.1.2.6 chr4.gen_37
PFL0285w;
Thioredoxin synthesis and recycling Thioredoxin MAL13P1.225
PF14_0545
PFI0790w
PFI1250w
Plasmoredoxin PFC0165w
Thioredoxin reductase 1.8.1.9 PFI1170c
Thioredoxin utilization Peroxiredoxin MAL7P1.159
Trx peroxidase (TPxP) is a PF14_0368, 2-cys
2-Cys peroxiredoxin PFL0725w; 2-cys
Glutathione peroxidase 1.11.1.9 PFL0595c
Ribonucleotide reductase, small chain 1.17.4.1 PF10_0154
PF14_0053
Oxidative protein folding Protein-disulfde isomerase 5.3.4.1 PF11_0352
PF14_0694
MAL8P1.17
PFI0950w
PF13_0272
Oxidoreductin (Ero1p) PF11_0251Malaria Journal 2004, 3:23 http://www.malariajournal.com/content/3/1/23
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permeable peroxide diffuses out of the digesting organelle
to be handled by the antioxidant machinery. One cannot
however exclude some efflux of O2
- from the food vacuole
to the parasite's cytosol. Additional amounts of O2
- can be
produced by the mitochondrion's electron transport, and
possibly other, as yet undefined, processes. But not less
importantly, O2
- can be produced by the reticuloendothe-
lial system. Phagocytes produce large quantities of O2
-
through the enzyme NADPH oxidase for use in oxygen-
dependent killing mechanisms, and this occurs in malar-
ial infections. Exogenous O2
- or H2O2 are most likely dealt
with the host cell Cu, Zn-SOD (that produce H2O2) and
by catalase which reduces the peroxide to water and
molecular oxygen. Inside the parasite, regardless of its ori-
gin, O2
-  is dismutated by superoxide dismutase (EC:
1.15.1.1; SOD) to H2O2. Two genes coding for iron-con-
taining SODs have been identified in the P. falciparum
genome and both are also very similar to the manganese-
containing SOD that is typically mitochondrial. Biochem-
ical analysis suggests that the gene product of PF08_0071
(see Table 1 throughout for the fuller description of these
genes and their products) is a typical Fe-SOD [10], but it
is not unlikely that the product of MAL6P1.194 is indeed
an Mn-SOD acting inside the mitochondrion. From Fig. 2
it can be seen that the transcription of this gene peaks at
30 hrs post invasion (HPI), at the trophozoite stage. The
processes producing O2
- in the parasite and their stage
dependence are not yet completely known, but the para-
site appears to be well equipped to deal with O2
- that may
be generated by the macrophages at the time of their max-
imal recognition of infected cells [11]. O2
- and H2O2 are
also generated by the endoplasmic reticulum-resident oxi-
doreductin (see below).
In addition to dismutated O2
-, H2O2 can also be generated
directly by some metabolic processes, such as the produc-
tion of pyridoxal phosphate (peaking at 18 HPI) or the
action of dihydroorotate oxidase (peaking at 20 HPI). The
parasite deals with this initial threat by means of the glu-
tathione and the thioredoxin (Trx) systems that compose
the cellular antioxidant defenses of both the parasite (see
below) and the host cell compartment if and when the
peroxide reaches it.
The glutathione system – biosynthesis and recycling
Glutathione is an abundant tripeptide that in most types
of cells is the major element of antioxidant defense. The
essential counterpart elements are glutathione peroxidase
that reduces both hydrogen and lipid peroxides, glutath-
ione S-transferase that conjugates electrophiles to reduced
Time dependent transcription of genes coding for  PF08_0071: Fe-superoxide dismutase Figure 2
Time dependent transcription of genes coding for 
PF08_0071: Fe-superoxide dismutase. The progress of stages 
along the cycle is shown on the upper X-axis and was taken 
from DeRisi transcriptome database
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Time dependent transcription of genes coding for enzymes  involved in the biosynthesis and recycling of glutathione Figure 3
Time dependent transcription of genes coding for enzymes 
involved in the biosynthesis and recycling of glutathione. ■  
(red square) PFI0925w: γ-glutamylcysteine synthetase; ▲  
(blue triangle) PFE0605c: glutathione synthetase; ▼  (green 
triangle) PF14_0192; glutathione reductase; ◆  (pink dia-
mond) PFA0590w: MRP ●  (black circle) PFL1410c: MRP The 
vertical line signifies the maximal transcription of glutathione 
reductase, and hence, glutathione recycling. The progress of 
stages along the cycle is shown on the upper X-axis and was 
taken from DeRisi transcriptome database
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glutathione (GSH) and some active membrane pumps
that can extrude oxidized glutathione (glutathione
disulfide; GSSG) or GSH conjugates. P. falciparum is capa-
ble of de novo synthesis of glutathione and of its recycling
[12,13]. The two enzymes that mediate the de novo synthe-
sis of glutathione (see Fig. 3), namely, γ-glutamyl-L-
cysteine synthetase (EC: 6.3.2.2; γ-GCS) and glutathione
synthase (EC: 6.3.2.3; GS) have been cloned [14,15], gene
structure has been analysed, and the biochemical features
of GS have been characterized. GSH serves as a substrate
for a number of reducing processes such as those medi-
ated by glutaredoxin, 1-cys peroxiredoxin (but see below
for indications that it uses mostly thioredoxin (Trx)) and
glutathione S-transferase (see below) with the resulting
formation of GSSG. The latter is reduced back to GSH by
glutathione reductase (EC: 1.8.1.7; GR), using NADPH
that is regenerated by the pentose phosphate pathway (see
Fig. 1). The genes of the two enzymes that reduce NADP
to NADPH are constitutively transcribed throughout the
cycle. P. falciparum GR has been cloned [16,17] and the
recombinant protein as well as the enzyme purified from
malarial parasites have been characterized in detail[18]. It
was shown by Northern blot analysis that the GR-coding
gene it transcribed in a stage-specific manner: only weakly
in ring, early trophozoite, and segmenter stages, while
major transcription occurs in the late trophozoite/early
schizont stage. This pattern is very similar to that obtained
in the present analysis (Fig. 3). As shown in Fig. 3, the
genes for the enzymes responsible for glutathione synthe-
sis and recycling are transcribed sequentially in the order
of their functional action. If the level and the timing of
transcription determine the level and the timing of trans-
lated product, then the maximal production of
glutathione is reached at 20 HPI. Mammalian cells are
capable of transporting GSSG, glutathione conjugates and
GSH as such in the presence of drugs and hence this trans-
port can affect the cellular level of GSH. This is accom-
plished by the so-called multidrug resistance pumps
(MRP's) [19]. Two genes putatively coding for such
pumps have been identified in the falciparum genome
and their functioning can perhaps be inferred from the
ability of the free parasite and the IRBC to release GSH/
GSSG to the extracellular medium [12,13,20]. The tran-
scription of one of these MRP-coding genes (PFA0590w)
peaks (Fig 3) to coincide with the peak of glutathione syn-
thase, as would be expected from their functional interac-
tion. However, the second MRP gene (PFL1410c) is
transcribed much earlier, mostly during the ring stage and
peaks again towards the end of the cycle. What does it
pump if the de novo biosynthesis of GSH is not yet func-
tional? As shown below, other GSH-utilizing enzymes
experience the same apparent deficit. Is it possible that the
second pump is working in reverse, i.e., pumping GSH
from the host cell into the parasite? This "provoking" sug-
gestion is amenable for experimental testing.
The glutathione system – utilization
It might be expected that genes coding enzymes that uti-
lize GSH will be transcribed after those that synthesize
and recycle it. This is indeed the case for most compo-
nents, but there are exceptions that require alternative
interpretations. In most eukaryote cells the reduction of
H2O2 and lipid peroxides at the expense of reduced glu-
tathione (GSH) is mediated by glutathione peroxidase
(EC: 1.11.1.9; GPx). However, biochemical characteriza-
tion of the parasite's recombinant protein indicates that
this enzyme has an overwhelming preference for Trx over
GSH [21]. Hence, the purported GPx gene is actually cod-
ing for a Trx peroxidase and the reduction of H2O2 and
lipid peroxides is done by other means. GPx must there-
fore be classified within the Trx system as is discussed
below.
A recombinant parasite glutathione-S-transferase (EC:
2.5.1.18; GST) has been produced and shown to reduce
cumene-hydroperoxide but not lipid-hydroperoxide[22].
GST, thus, compensates partially for the absence of a gen-
uine GPx. Significantly, the GST-coding gene is tran-
scribed during most of the parasite's intra-eryhtrocytic life
cycle. Although the major role of this enzyme is to conju-
gate GSH to various toxic substances, preparing them for
export, a small percentage of its activity entails peroxida-
tive action. One wonders about the source of GSH needed
for these activities during the early stages, before the peak-
ing of GSH synthesis and recycling.
Peroxiredoxins (Prx) comprise a group of antioxidant
enzymes having peroxidase activity capable of reducing
H2O2  and organic hydroperoxides. Unlike other
peroxidases, their enzymatic activity does not entail met-
als or prosthetic groups as cofactors. Peroxidation of both
H2O2 and organic hydroperoxides is performed by 1-cys
peroxiredoxin which accepts GSH as a reducing agent
[23]. However, Trx-dependency of a 92 % identical pro-
tein has been shown [24]. The transcription of the gene
peaks at 26 HPI (Fig. 4), following full activation of the
GSH synthesis and recycling machinery and coinciding
with the peak of endogenous ROS production.
Other GSH-utilizing mechanisms operate in the parasite.
Most notably are functions catalyzed by glutaredoxins.
Glutaredoxin has vicinal thiols in the active site enabling
it to catalyse glutathione-disulfide oxidoreductions such
as the reduction of ribonucleotide reductase as well as the
direct reduction of H2O2. Glutaredoxins are generally
reduced by glutathione, but Trx can serve as an alternative
substrate. One gene coding for glutaredoxin (PFC0271c)
and two genes coding for glutaredoxin-like proteins (the
exact function is unknown) have been found in the
genome of P. falciparum. As shown in Fig. 4 the glutare-
doxin-coding gene is transcribed maximally between 19Malaria Journal 2004, 3:23 http://www.malariajournal.com/content/3/1/23
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and 28 HPI, thus coinciding with the transcription of its
putative substrate ribonucleotide reductase (maximal
transcription 31–33 HPI) suggesting that glutaredoxin is
the major reducer of this enzyme. On the other hand, glu-
taredoxin-like proteins do not possess the classical con-
served active site motif of glutaredoxins, they have only 1-
Cys residue, and are not active in the general glutaredoxin
assay [25].
More than 200 mammalian proteins with reactive sulfhy-
dryl sites have been identified in recent years as candidates
for coordinate redox control of diverse cell functions [26].
The state of sulfhydryl oxidation is maintained by thiore-
doxins, glutaredoxins, and glutathione [27]. Outstanding
among these proteins are proteases that are activated by
reduction and inhibited by oxidation. The possible com-
parable regulation of the activity of falcipains has not
been investigated heretofore. Such regulation is under-
scored by the recent demonstration that falcipains are not
restricted to haemoglobin digestion [28], but are also
involved in invasion [29] and rupture of the mature sch-
izont [30], The present analysis establishes the time-scale
of such possible regulation.
The glyoxalase pathway
Genes coding for two other enzymes that involve the uti-
lization or the generation of GSH have been identified in
the genome of P. falciparum: lactoylglutathione lyase (EC:
4.4.1.5; glyoxalase I) and hydoxyacylglutathione hydro-
lase (EC: 3.1.2.6; glyoxalase II) and their biochemical
functions have been revealed [31]. These enzymes partici-
pate in a metabolic pathway that catalyses the
detoxification of α-oxoaldehydes to the corresponding
aldonic acids, using catalytic amount of GSH as cofactor.
α-Oxoaldehydes react with guanyl residues in DNA and
RNA, and with cysteine, lysine and arginine residues in
proteins. The modification of DNA induces mutagenesis
and apoptosis. The modification of proteins leads to pro-
tein degradation and activation of a cytokine-mediated
immune response [32]. A possible substrate of the gly-
oxalase system in the parasite is the glycolytic intermedi-
ate dihydroxyacetone phosphate that forms
spontaneously the toxic electrophile methylglyoxal, an α-
oxoaldehyde. Although this detoxification system seems
essential to the parasite (about 10 % of the lactate pro-
duced in P. falciparum is D-lactate, the final product of the
glyoxalase pathway[31]) it needs only catalytic amounts
of GSH that is essentially recycled by the system itself. Gly-
oxalase I has been recently cloned, expressed and its bio-
chemical properties have been characterized [33]. The
transcripts of glyoxalase I gene peaks at 28 HPI, while
those of the two genes coding for glyoxalase II peak at 12
and 25 HPI, suggesting the expression of glyoxalase I
determines the onset of the detoxification pathway. The
importance of this pathway to the parasite can be inferred
from the inhibitory effect of glyoxalase inhibitors on par-
asite growth [34], but the pathway probably draws little
on the stores of GSH.
Oxidative protein folding – a source of GSSG and ROS
Post-translational modification and maturation of pro-
teins in the endoplasmic reticulum involves disulfide for-
mation [35]. This activity is mediated by protein-disulfide
isomerases (PDI) and oxidoreductin, both having Trx-like
activity. In the oxidizing environment of the endoplasmic
reticulum, PDI catalyzes both the oxidation and isomeri-
zation of disulfides on nascent polypeptides and simulta-
neously becomes itself reduced [36]. Four genes coding
for PDI are transcribed during the erythrocytic cycle. Their
gene ID's and times of maximal transcript level are (data
not shown): MAL8P1.17 (31 HPI), PFI0950w (33 HPI),
PF11_0352 (32 HPI), PF13_0272 (34 HPI; this gene has
not been annotated as PDI, but close inspection of its
homology to other genes clearly indicates that it is a PDI)
and PF14_0694 (39 HPI). As indicated by one of the
reviewers of this report, although these genes were anno-
Time dependent transcription of genes coding for enzymes  and proteins involed in the utilization of glutathione Figure 4
Time dependent transcription of genes coding for enzymes 
and proteins involed in the utilization of glutathione. ▲  (blue 
triangle) PF08_0131: 1-cys peroxidoxin; ◆  (pink diamond) 
PFC0271c: glutaredoxin; ▼  (green triangle) MAL6P1.72: glu-
taredoxin-like protein;  ■  (red square) PFC0205c: glutare-
doxin-like protein; ●  (black circle) PF14_0187: glutathione S-
transferase. The vertical line signifies the maximal transcrip-
tion of GR, and hence, glutathione recycling. The progress of 
stages along the cycle is shown on the upper X-axis and was 
taken from DeRisi transcriptome database
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tated as PDI in PlasmoDB, no evidence indicates they are
"true" PDI. Only the translated MAL8P1.17 gene shows
the classical organization of PDI. The others contain
either one active site (instead of two) and in that case, they
could act as weak oxido-reducatses activity but not as iso-
merases. Alternatively, they have mutated amino acids
(Cys->Ser; data not shown) in the active site and in that
case, they may act as isomerase but certainly not as oxido-
isomerase. The late transcription of the PDI gene may be
involved in the maturation of merozoite proteins, such as
the EBA-175, that accumulate in the micronemes and
characteristically contain conserved cysteine domains
[37] and the rhoptry protein apical membrane antigen 1
(AMA-1) [38] known for its numerous disulfide bonds.
Some of these genes seem to have a transit signal sequence
that may suggest their localization to the endoplasmic
reticulum. Recently, oxidoreductin (Ero1p) has been
identified as a candidate enzyme for the maintenance of
redox status in the ER. Oxidoreductin of P. falciparum
(PF11_0251) peaks twice, at 6HPI and at 33 HPI).
Oxidoreductin, is oxidized by molecular oxygen in an
FAD-dependent manner, thereby producing O2
-, is an
FAD-dependent enzyme. Oxidoreductin subsequently
acts as a specific oxidant of reduced PDI, which can then
directly oxidize again disulfide bonds in folding proteins.
Thus, this activity results in ROS production. GSH can
also participate in the reduction of -S-S- bonds in oxidized
proteins and thereby be oxidized to GSSG. It is not clear
how glutathione is transported across the ER membrane,
but cells involved in intensive secretion are also known to
secrete GSSG. In the plasmodium-infected RBC, the desti-
nation of such GSSG is presumably the host cell compart-
ment. The quantitative contribution of these processes to
the overall oxidative stress and glutathione metabolism is
impossible to evaluate at the present time.
The thioredoxin system
Thioredoxins (Trx) are small disulphide-containing redox
proteins that have been found in all the kingdoms of liv-
ing organisms [39]. Trx serves as a general protein disul-
phide oxidoreductase. It interacts with a broad range of
proteins by a redox mechanism based on reversible oxida-
tion of two vicinal cysteine thiol groups to a disulphide,
accompanied by the transfer of 2 electrons and 2 protons.
The net result is the covalent interconversion of a disul-
phide and a dithiol. Oxidized Trx is recycled by Trx reduct-
ase (TrxR) along the following path:
TrxR-S2 + NADPH + H+ _ TrxR-(SH)2 + NADP+   (1)
Trx-S2 + TrxR-(SH)2 _ Trx-(SH)2 + TrxR-S2   (2)
Protein-S2 + Trx-(SH)2 _ Protein-(SH)2 + Trx-S2   (3)
TrxR catalyses the reduction of oxidised thioredoxin (Trx-
S2) by NADPH using FAD and its redox-active disulphide
(steps 1 and 2). Reduced thioredoxin (TrxR-(SH)2) then
directly reduces the disulphide in the substrate protein
(step 3).
The thioredoxin system of P. falciparum has been charac-
terized [2]. The Trx system supplies reducing equivalents
for a wide variety of acceptors, most notably
ribonucleotide reductase (only the gene coding for ribo-
nucleoside-diphosphate reductase, EC: 1.17.4.1, is found
in the plasmodium genome; maximal transcription 31–
33 HPI) and is very efficient in the nonspecific reduction
of protein disulfide bonds. The transcription of the vari-
ous genes of the Trx system is shown in Fig. 5. There are
altogether 4 genes coding for Trx (Table 1), but only two
are found in the DeRisi transcriptome database. Two
genes coding for Trx are transcribed in a sequential mode.
The missing genes can be found in the Winzeler labora-
tory site http://carrier.gnf.org/publications/CellCycle/.
The maximal transcription of genes PF14_0545,
PFI0790w and of PFI1250w (results for this gene are con-
flicting; see details in the web site) occurs at the early sch-
izont stage, i.e. when the transcripts of the other two genes
are at their minimum. The product of PFC0165w has been
recently characterized as unique to P. falciparum and thus
named plasmoredoxin [40]. It can be reduced by Trx and
glutaredoxin, but only minimally by GSH. Plasmoredoxin
can reduce GSSG and ribonucleotide reductase. The tran-
script of the Trx-coding MAL13P1.225 is already high
immediately following invasion (Fig. 5) and remains
highly expressed throughout the ring stage. The transcript
of the plasmoredoxin-coding gene peaks at 20 HPI. TrxR
(EC: 1.8.1.9) peaks considerably later, at 30 HPI, casting a
doubt about the efficacy of both products of Trx genes to
perform their function in the absence of recycling: oxi-
dized Trx must be reduced by TrxR in order to be able to
carry out its functions. Nevertheless, the transcription of
the other Trx genes at the early schizont stage
(PF14_0545, PFI0790w and PFI1250w; data not shown)
is suitably timed with the transcription of TrxR. Reduced
Trx is also involved in the action of several peroxidases
which may be functioning at this stage.
The transcriptions of thioredoxin peroxidase (peaking at
32 HPI), the gene annotated as GSH peroxidase but exper-
imentally shown to utilize Trx (a broad peak between 21
and 32 HPI) are well coordinated with that of TrxR (see
Fig. 6). The transcript of the gene coding for 2-cys perox-
iredoxin that utilizes Trx as a reducing agent [41], peaks
for more than 20 hours starting at 7 HPI. This is possibly
amongst the longest lasting transcripts in the transcrip-
tome of P. falciparum. The importance of 2-cys peroxire-
doxin for antioxidant defense is evidenced by the greater
sensitivity of the null mutant to superoxide and to nitricMalaria Journal 2004, 3:23 http://www.malariajournal.com/content/3/1/23
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oxide [42]. But, although these findings imply that the
enzyme protects the parasite from oxidative and nitrosoa-
tive stresses, the availability of reduced Trx for these activ-
ities before 31 HPI when the TrxR transcript peaks,
remains to be established.
Implications for transcription control
The analysis of the transcriptome of P. falciparum [8] has
revealed two major parameters that characterize func-
tional clusters of genes, the time of peaking and the ampli-
fication of gene transcription (expressed as peak-to-
trough amplitude of the expression profile). The
amplification was suggested to express the level of
transcriptional regulation. An analysis of these parameters
done on the genes discussed in the present study is shown
in Fig. 7. In general, the amplification of most enzymes
and proteins of both the glutathione and the Trx systems
resembles that of basic metabolic functions, including gly-
colysis and nucleotide synthesis (amplification range 5 to
10). Exceeding this range are 1-cys peroxiredoxin (28-
fold) and two PDI genes (36- and 39-fold). Similarly high
amplifications were almost exclusively found for genes
that are involved in the invasion process that is expectedly
unique to an intracellular parasite. These considerations
suggest that overly amplified transcripts identified in this
study are also related to unique processes in the parasite.
Conclusions
In previous functional analyses of the transcriptome of P.
falciparum it was contended (and shown) that the parasite
has evolved a functionally concerted mode of
transcriptional regulation. Thus, functional clusters of
genes related to a particular function are transcribed in
rational sequence that corresponds to the timing of the
physiology and the biochemistry of the intraerythrocytic
phase of the parasite life cycle. In-phase co-expression was
observed for genes of many general processes such as RNA
and DNA synthesis and for parasite-specific processes
such as erythrocyte invasion. From the present study, it is
clear that both in the glutathione and the thioredoxin sys-
tems not all transcriptions are in phase. A detailed analysis
of this complex expression pattern reveals rational con-
nections between gene expression and metabolic function
of the protein products. For most factors of both studied
systems, the expression of users (GSH and Trx users) lags
behind that of the producers (de novo synthesis and
recycling). However, there are exceptions to this rule,
Time dependent transcription of genes coding for enzymes  andproteins involved in the biosynthesis and recycling of  thioredoxin Figure 5
Time dependent transcription of genes coding for enzymes 
andproteins involved in the biosynthesis and recycling of 
thioredoxin. ●  (black circle) MAL13P1.225: thioredoxin; ■  
(red square) PFC0165w: plasmoredoxin; ▲  (blue triangle) 
PFI1170c: thioredoxin reductase. The vertical line signifies 
the maximal transcription of TrxR, and hence, the recycling 
of thioredoxin. The progress of stages along the cycle is 
shown on the upper X-axis and was taken from DeRisi tran-
scriptome database
Thioredoxin synthesis and recycling
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Time dependent transcription of genes coding for enzymes  and proteins involved in the utilization of thioredoxin Figure 6
Time dependent transcription of genes coding for enzymes 
and proteins involved in the utilization of thioredoxin. ●  
PF1_0368: 2-cys peroxiredoxin; ▲  PFL0725w: thioredoxin 
peroxidase; ■  PFL0595c: "Glutathione" peroxidase (see 
text). The progress of stages along the cycle is shown on the 
upper X-axis and was taken from DeRisi transcriptome 
database
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which represent unexpected chains of events in classical
biological systems (predators never precede their prey).
Such discrepancies point out to possible missing links in
the metabolic pathways based on the current status of the
gene sequencing and annotations. Alternatively, these
could indicate a nonlinear relationship between transcrip-
tion and translation. Only detailed analysis of the time-
dependent levels of protein and of the pertinent low
molecular weight substrates/products can solve this
apparent paradox and hints to the unresolved meaning of
the variable duration of the transcripts: is it related to tran-
script or to protein stability.
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